Michael Naccache

Michael Naccache supports economic experts through all stages of consulting and litigation work related to antitrust matters, with a focus on healthcare provider and insurer issues. His review of discovery materials, analysis of large claims and other complex data sets, and organization of report submissions contributes to clear assessments of anticompetitive conduct and antitrust risk for government and industry clients. Michael also has experience working on mergers and monopolization cases involving technology and consumer goods markets, including AT&T-Time Warner, Arista v. Cisco, and GE-Electrolux.

BA, Economics, Political Science, Mathematical Methods in the Social Sciences, Northwestern University

• Provided support to the expert on behalf of the Department of Justice (DOJ) in its litigation effort to block the merger between AT&T and Time Warner Inc.
• Supported testifying expert on behalf of Arista Networks’ antitrust suit against Cisco Systems (Arista Networks, Inc. v. Cisco Systems, Inc.). Evaluated the impact of Cisco’s copyright lawsuit on the industry and consumers of Ethernet switches, assessed the impact of these actions on Arista’s sales, and calculated associated damages to Arista. 
• Supported the expert on behalf of DOJ in the matter United States v. AB Electrolux, Electrolux North America, Inc., and General Electric Company. 
• Led data processing efforts and supported expert analysis on behalf of the Washington State Attorney General’s office in its litigation effort to unwind CHI Franciscan Health’s acquisitions of two physician groups: WestSound Orthopaedics and The Doctors Clinic.
• On behalf of Steward Health Care in Steward Health Care System LLC et al. v. Blue Cross & Blue Shield of Rhode Island, supported the expert in providing written and deposition testimony on monopoly power, monopsony power, and exclusionary conduct. 
• On behalf of Humana in connection with its proposed merger with Aetna, provided support for responses to the DOJ's second request and analyzed likely competitive effects in the sale of individual health insurance on public exchanges.